NCT05361668 2025-10-31Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid SyndromeCrinetics Pharmaceuticals Inc.Phase 2 Active not recruiting36 enrolled 19 charts
NCT02299089 2017-12-15Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)Camurus ABPhase 2 Completed12 enrolled 18 charts